Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Processa Pharmaceuticals, Inc. PCSA

Full chart Compare
Set alert

Price alert · PCSA

All alert types
1.84 USD -0.09 (-4.91%)

At closeNov 6, 2026, 4:00 AM EST

1.82 -0.02 -1.09%

Pre-market · Nov 6, 4:00 AM ET

1.78 Day range 1.91
1.04 52-week range 8.88
YTD
-36.11%
1 year
-78.35%

Financial health

Altman Z-Score

-92.99 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B-2 / 5 overall

  • DCF 5
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.3×
FY 2016: -1.2×FY 2017: -77.0×FY 2018: -35.5×FY 2019: -29.6×FY 2020: -2.6×FY 2021: -6.6×FY 2022: -0.6×FY 2023: -0.8×FY 2024: -0.2×FY 2025: -0.3×
FY 2016 5y median -0.6× FY 2025
P/S 0.0×
FY 2016: 209×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.7×
FY 2016: -0.4×FY 2017: 384×FY 2018: 13.9×FY 2019: 12.4×FY 2020: 2.2×FY 2021: 2.9×FY 2022: 2.4×FY 2023: 1.8×FY 2024: 1.6×FY 2025: 0.7×
FY 2016 5y median 1.8× FY 2025
P/FCF -0.3×
FY 2016: -15.6×FY 2017: -85.6×FY 2018: -36.0×FY 2019: -36.2×FY 2020: -15.7×FY 2021: -8.6×FY 2022: -1.8×FY 2023: -1.1×FY 2024: -0.2×FY 2025: -0.3×
FY 2016 5y median -1.1× FY 2025
EV/EBITDA 0.1×
FY 2016: -29.4×FY 2017: -79.7×FY 2018: -34.3×FY 2019: -32.0×FY 2020: -2.4×FY 2021: -5.4×FY 2022: -0.4×FY 2023: -0.4×FY 2024: -0.1×FY 2025: 0.1×
FY 2016 5y median -0.4× FY 2025
EV/Sales 0.0×
FY 2016: 531×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -301.9%
FY 2016: -6.4%FY 2017: -1.2%FY 2018: -2.8%FY 2019: -2.8%FY 2020: -6.4%FY 2021: -11.6%FY 2022: -54.2%FY 2023: -91.9%FY 2024: -415.8%FY 2025: -301.9%
FY 2016 5y median -91.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 72.4%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -38430.4%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -6719.6%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -243.2%
FY 2016: 14.3%FY 2017: -497.5%FY 2018: -38.8%FY 2019: -41.9%FY 2020: -83.0%FY 2021: -44.8%FY 2022: -367.1%FY 2023: -222.9%FY 2024: -698.6%FY 2025: -243.2%
FY 2016 5y median -243.2% FY 2025
ROIC -250.8%
FY 2016: -123.9%FY 2017: -63.0%FY 2018: -30.3%FY 2019: -31.6%FY 2020: -58.5%FY 2021: -45.4%FY 2022: -263.1%FY 2023: -222.9%FY 2024: -681.0%FY 2025: -250.8%
FY 2016 5y median -250.8% FY 2025
ROA -173.6%
FY 2016: -10379.4%FY 2017: -62.2%FY 2018: -28.5%FY 2019: -30.9%FY 2020: -75.5%FY 2021: -43.2%FY 2022: -318.2%FY 2023: -192.2%FY 2024: -367.0%FY 2025: -173.6%
FY 2016 5y median -192.2% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -95.6%FY 2017: -100.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -16.1%
FY 2016: -171.4%FY 2017: 6.2%FY 2018: -151.0%FY 2019: 13.0%FY 2020: -284.6%FY 2021: 19.8%FY 2022: -67.0%FY 2023: 43.4%FY 2024: -5.2%FY 2025: -16.1%
FY 2016 FY 2025
EPS (diluted) 89.3%
FY 2016: 90.0%FY 2017: 73.2%FY 2018: -77.5%FY 2019: 14.3%FY 2020: -317.2%FY 2021: 70.6%FY 2022: -128.2%FY 2023: 75.1%FY 2024: 54.4%FY 2025: 89.3%
FY 2016 FY 2025
Free Cash Flow -1.2%
FY 2016: 92.3%FY 2017: -2401.2%FY 2018: -122.6%FY 2019: 26.2%FY 2020: -14.3%FY 2021: -177.3%FY 2022: -10.2%FY 2023: 16.0%FY 2024: -39.5%FY 2025: -1.2%
FY 2016 FY 2025

Financial Health

Current Ratio 2.5×
FY 2016: 0.0×FY 2017: 1.1×FY 2018: 3.1×FY 2019: 0.8×FY 2020: 13.3×FY 2021: 18.9×FY 2022: 8.4×FY 2023: 7.7×FY 2024: 1.2×FY 2025: 2.5×
FY 2016 5y median 7.7× FY 2025
Quick Ratio 2.5×
FY 2016: 0.0×FY 2017: 1.1×FY 2018: 3.1×FY 2019: 0.8×FY 2020: 13.3×FY 2021: 18.9×FY 2022: 8.4×FY 2023: 7.7×FY 2024: 1.2×FY 2025: 2.5×
FY 2016 5y median 7.7× FY 2025
Debt / Equity 0.0×
FY 2016: -0.7×FY 2017: 6.6×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2016: -17.8×FY 2017: 0.2×FY 2018: 0.4×FY 2019: -0.1×FY 2020: 1.1×FY 2021: 1.5×FY 2022: 0.2×FY 2023: 0.4×FY 2024: 0.1×FY 2025: 0.4×
FY 2016 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2016: -7.8×FY 2017: -50.5×FY 2018: -28.1×FY 2019: -107×FY 2020: -53.8×FY 2021: -33518×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31